329 related articles for article (PubMed ID: 24405633)
1. Endometrial progesterone resistance and PCOS.
Li X; Feng Y; Lin JF; Billig H; Shao R
J Biomed Sci; 2014 Jan; 21(1):2. PubMed ID: 24405633
[TBL] [Abstract][Full Text] [Related]
2. Altered gene expression profiling in endometrium: evidence for progesterone resistance.
Aghajanova L; Velarde MC; Giudice LC
Semin Reprod Med; 2010 Jan; 28(1):51-8. PubMed ID: 20104428
[TBL] [Abstract][Full Text] [Related]
3. Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations.
Ferreira SR; Motta AB
Curr Med Chem; 2018; 25(15):1792-1804. PubMed ID: 29210631
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome.
Albaghdadi AJH; Kan FWK
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808965
[TBL] [Abstract][Full Text] [Related]
5. High level of visfatin and the activation of Akt and ERK1/2 signaling pathways are associated with endometrium malignant transformation in polycystic ovary syndrome.
Tian W; Zhang H; Zhang Y; Wang Y; Zhang Y; Xue F; Song X; Zhang H
Gynecol Endocrinol; 2020 Feb; 36(2):156-161. PubMed ID: 31452406
[TBL] [Abstract][Full Text] [Related]
6. Endometrium in PCOS: Implantation and predisposition to endocrine CA.
Giudice LC
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):235-44. PubMed ID: 16772154
[TBL] [Abstract][Full Text] [Related]
7. Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1†.
Khatun M; Arffman RK; Lavogina D; Kangasniemi M; Laru J; Ahtikoski A; Lehtonen S; Paulson M; Hirschberg AL; Salumets A; Andersson LC; Piltonen TT
Biol Reprod; 2020 Feb; 102(2):306-315. PubMed ID: 31494675
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome is associated with a higher risk of premalignant and malignant endometrial polyps in premenopausal women: a retrospective study in a tertiary teaching hospital.
Lu L; Luo J; Deng J; Huang C; Li C
BMC Womens Health; 2023 Mar; 23(1):127. PubMed ID: 36964546
[TBL] [Abstract][Full Text] [Related]
9. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
[TBL] [Abstract][Full Text] [Related]
10. In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia.
Bacallao K; Leon L; Gabler F; Soto E; Romero C; Valladares L; Vega M
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):163-9. PubMed ID: 18467089
[TBL] [Abstract][Full Text] [Related]
11. TLR4-Associated IRF-7 and NFκB Signaling Act as a Molecular Link Between Androgen and Metformin Activities and Cytokine Synthesis in the PCOS Endometrium.
Hu M; Zhang Y; Li X; Cui P; Sferruzzi-Perri AN; Brännström M; Shao LR; Billig H
J Clin Endocrinol Metab; 2021 Mar; 106(4):1022-1040. PubMed ID: 33382900
[TBL] [Abstract][Full Text] [Related]
12. [Extracellular signal-regulated protein kinase activation in endometrium with polycystic ovary syndrome and its significance].
Song XR; Zhang HY; Zhang YF; Han YK; Li KJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):767-71. PubMed ID: 21176559
[TBL] [Abstract][Full Text] [Related]
13. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.
Jeong JW; Lee HS; Lee KY; White LD; Broaddus RR; Zhang YW; Vande Woude GF; Giudice LC; Young SL; Lessey BA; Tsai SY; Lydon JP; DeMayo FJ
Proc Natl Acad Sci U S A; 2009 May; 106(21):8677-82. PubMed ID: 19439667
[TBL] [Abstract][Full Text] [Related]
14. Uterine progesterone signaling is a target for metformin therapy in PCOS-like rats.
Hu M; Zhang Y; Feng J; Xu X; Zhang J; Zhao W; Guo X; Li J; Vestin E; Cui P; Li X; Wu XK; Brännström M; Shao LR; Billig H
J Endocrinol; 2018 May; 237(2):123-137. PubMed ID: 29535146
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
16. MUC1 as a discriminator between endometrium from fertile and infertile patients with PCOS and endometriosis.
Margarit L; Taylor A; Roberts MH; Hopkins L; Davies C; Brenton AG; Conlan RS; Bunkheila A; Joels L; White JO; Gonzalez D
J Clin Endocrinol Metab; 2010 Dec; 95(12):5320-9. PubMed ID: 20826587
[TBL] [Abstract][Full Text] [Related]
17. Scaffold-Free Endometrial Organoids Respond to Excess Androgens Associated With Polycystic Ovarian Syndrome.
Wiwatpanit T; Murphy AR; Lu Z; Urbanek M; Burdette JE; Woodruff TK; Kim JJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):769-80. PubMed ID: 31614364
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
Piltonen TT; Chen J; Erikson DW; Spitzer TL; Barragan F; Rabban JT; Huddleston H; Irwin JC; Giudice LC
J Clin Endocrinol Metab; 2013 Sep; 98(9):3765-75. PubMed ID: 23824412
[TBL] [Abstract][Full Text] [Related]
19. Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.
Kim TH; Lee DK; Cho SN; Orvis GD; Behringer RR; Lydon JP; Ku BJ; McCampbell AS; Broaddus RR; Jeong JW
Cancer Res; 2013 Aug; 73(16):5090-9. PubMed ID: 23811943
[TBL] [Abstract][Full Text] [Related]
20. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles.
Savaris RF; Groll JM; Young SL; DeMayo FJ; Jeong JW; Hamilton AE; Giudice LC; Lessey BA
J Clin Endocrinol Metab; 2011 Jun; 96(6):1737-46. PubMed ID: 21411543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
